Acute administration of unacylated ghrelin (AZP 01) alone or in combination with ghrelin and effects on high molecular weight and total adiponectin levels in non-diabetic obese patients.

Trial Profile

Acute administration of unacylated ghrelin (AZP 01) alone or in combination with ghrelin and effects on high molecular weight and total adiponectin levels in non-diabetic obese patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Mar 2011

At a glance

  • Drugs Unacylated ghrelin (Primary) ; Ghrelin
  • Indications Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top